<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31324202</article-id><article-id pub-id-type="publisher-id">2539</article-id><article-id pub-id-type="doi">10.1186/s13054-019-2539-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Influenza virus-related critical illness: pathophysiology and epidemiology</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6489-6294</contrib-id><name><surname>Kalil</surname><given-names>Andre C.</given-names></name><address><phone>402 559-8650</phone><email>akalil@unmc.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thomas</surname><given-names>Paul G.</given-names></name><address><email>paul.thomas@stjude.org</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0666 4105</institution-id><institution-id institution-id-type="GRID">grid.266813.8</institution-id><institution>Department of Internal Medicine, Division of Infectious Diseases, </institution><institution>University of Nebraska Medical Center, </institution></institution-wrap>Omaha, NE 68198 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0224 711X</institution-id><institution-id institution-id-type="GRID">grid.240871.8</institution-id><institution>Immunology Department, </institution><institution>St. Jude Children&#x02019;s Research Hospital, </institution></institution-wrap>Memphis, TN USA </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>23</volume><elocation-id>258</elocation-id><history><date date-type="received"><day>19</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Influenza virus affects the respiratory tract by direct viral infection or by damage from the immune system response. In humans, the respiratory epithelium is the only site where the hemagglutinin (HA) molecule is effectively cleaved, generating infectious virus particles. Virus transmission occurs through a susceptible individual&#x02019;s contact with aerosols or respiratory fomites from an infected individual. The inability of the lung to perform its primary function of gas exchange can result from multiple mechanisms, including obstruction of the airways, loss of alveolar structure, loss of lung epithelial integrity from direct epithelial cell killing, and degradation of the critical extracellular matrix.</p><p id="Par2">Approximately 30&#x02013;40% of hospitalized patients with laboratory-confirmed influenza are diagnosed with acute pneumonia. These patients who develop pneumonia are more likely to be &#x0003c;&#x02009;5&#x02009;years old, &#x0003e;&#x02009;65&#x02009;years old, Caucasian, and nursing home residents; have chronic lung or heart disease and history of smoking, and are immunocompromised.</p><p id="Par3">Influenza can primarily cause severe pneumonia, but it can also present in conjunction with or be followed by a secondary bacterial infection, most commonly by <italic>Staphylococcus aureus</italic> and <italic>Streptococcus pneumoniae</italic>. Influenza is associated with a high predisposition to bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial pneumonia are now known to occur with a frequency of 30&#x02013;50% in both adult and pediatric populations. The H3N2 subtype has been associated with unprecedented high levels of intensive care unit (ICU) admission.</p><p id="Par4">Influenza A is the predominant viral etiology of acute respiratory distress syndrome (ARDS) in adults. Risk factors independently associated with ARDS are age between 36 and 55&#x02009;years old, pregnancy, and obesity, while protective factors are female sex, influenza vaccination, and infections with Influenza A (H3N2) or Influenza B viruses.</p><p id="Par5">In the ICU, particularly during the winter season, influenza should be suspected not only in patients with typical symptoms and epidemiology, but also in patients with severe pneumonia, ARDS, sepsis with or without bacterial co-infection, as well as in patients with encephalitis, myocarditis, and rhabdomyolysis.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Influenza</kwd><kwd>Epidemiology</kwd><kwd>Pneumonia</kwd><kwd>Sepsis</kwd><kwd>ARDS</kwd><kwd>Complications</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><sec id="Sec2"><title>The pathophysiology of influenza virus infection</title><p id="Par6">Human influenza virus infection replicates primarily in the respiratory epithelium. Other cell types, including many immune cells, can be infected by the virus and will initiate viral protein production. However, viral replication efficiency varies among cell types, and, in humans, the respiratory epithelium is the only site where the hemagglutinin (HA) molecule is effectively cleaved, generating infectious virus particles. Virus transmission occurs when a susceptible individual comes into contact with aerosols or respiratory fomites from an infected individual [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par7">The ferret has traditionally been used as a model of influenza transmission as most human influenza viruses do not need any adaptation to infect and transmit among ferrets. Studies in ferrets have identified the soft palate as a major source of influenza viruses that are transmitted between individuals. Notably, the soft palate is enriched in &#x003b1;2,6-linked sialic acids, which are preferred by the hemagglutinin proteins currently found in circulating human influenza viruses [<xref ref-type="bibr" rid="CR2">2</xref>]. This enrichment also occurs in the soft palate of humans [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par8">The primary mechanism of influenza pathophysiology is a result of lung inflammation and compromise caused by direct viral infection of the respiratory epithelium, combined with the effects of lung inflammation caused by immune responses recruited to handle the spreading virus (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). This inflammation can spread systemically and manifest as a multiorgan failure, but these consequences are generally downstream of lung compromise and severe respiratory distress [<xref ref-type="bibr" rid="CR4">4</xref>]. Some associations have also been observed between influenza virus infection and cardiac sequelae, including increased risk of myocardial disease in the weeks following influenza virus infection. The mechanisms of this, beyond a general inflammatory profile, are still unresolved [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Host and viral mechanisms of influenza-associated pathogenesis</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3">Host and viral mechanisms of influenza-associated pathology</th></tr><tr><th>Direct viral induced pathology</th><th>Innate immune responses</th><th>Adaptive immune responses</th></tr></thead><tbody><tr><td><p>&#x02003; &#x02022; Epithelial cell death (apoptosis and necrosis)</p><p>&#x02003; &#x02022; Alveolar compromise</p><p>&#x02003; &#x02022; Denudation of the airways</p></td><td><p>&#x02022; Local and systemic cytokine production</p><p>&#x02022; Innate immune cellular infiltration (neutrophils, inflammatory monocytes)</p><p>&#x02022; Extracellular matrix degradation</p></td><td><p>&#x02022; Exuberant T cell responses (CD4 and CD8)</p><p>&#x02022; Excess cytokine production</p><p>&#x02022; Immune-cell mediated epithelial denudation</p><p>&#x02022; Amplification of inflammation and local and systemic cytokine production</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec3"><title>How influenza triggers ARDS</title><p id="Par9">Influenza virus infects respiratory epithelial cells that line the upper (including nasal) through lower (to the alveoli) respiratory tract. A key parameter in determining the extent of associated disease is the degree to which the lower respiratory tract becomes invaded by the virus [<xref ref-type="bibr" rid="CR7">7</xref>]. The infection of alveolar epithelial cells in particular appears to drive the development of severe disease, destroying the key mediators of gas exchange and allowing viral exposure to endothelial cells. Early interactions between influenza virus, the alveolar macrophages that are resident in the lung airways, and the epithelial lining are an important determinant for alveolar disease progression [<xref ref-type="bibr" rid="CR8">8</xref>]. Once this fragile layer is breached, cytokine and viral antigen exposure to the endothelial layer can amplify inflammation, with endothelial cells a major source of pro-inflammatory cytokines that will drive the magnitude and character of subsequent innate and adaptive immune responses [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par10">Ultimately, the involvement of significant portions of the airways in an infectious response, either by direct viral infection or by damage from the responding immune system, represents a physiological failure. The inability of the lung to perform its primary function of gas exchange can result from multiple, non-exclusive mechanisms, including obstruction of the airways, loss of alveolar structure, loss of lung epithelial integrity from direct epithelial cell killing, and degradation of the critical extracellular matrix that maintains the structure of the lung [<xref ref-type="bibr" rid="CR10">10</xref>]. This latter area has been relatively understudied, with the relationship between the immune response and extracellular matrix structure not fully elucidated. Further, the key pathways regulating extracellular matrix degradation and regeneration in the context of infection and in the restoration of healthy lung functioning are not fully understood [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par11">Therapies targeting these pathways may have efficacy later in the response, after traditional antivirals have been found to have reduced effects [<xref ref-type="bibr" rid="CR13">13</xref>]. Towards this end, a report found that inhibition of the collagenase MT1-MMP (MMP14) limited tissue damage and improved survival in a mouse model of severe influenza virus infection and in a model of influenza-pneumococcal coinfection [<xref ref-type="bibr" rid="CR14">14</xref>]. Targeting the downstream effects of inflammation and immune-associated lung damage may be a viable means of limiting influenza-associated pathology [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par12">Other approaches to address the host response directly rather than solely focusing on the virus have included targeting innate immune pathways that amplify inflammatory signals and contribute to epithelial damage. The inflammasome, an innate signaling complex that is required for IL-1&#x003b2; and IL-18 secretion has been implicated in multiple studies as influenza-associated pathology [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Suppressing inflammasome activation later in infection, by targeting NLRP3 (a key component of inflammasome signaling) downstream of influenza has had positive effects on recovery in animal models [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Following inflammasome activation, secondary cytokine and chemokine signaling can lead to the recruitment of tissue-damaging neutrophil and inflammatory monocyte populations. Experiments blocking CXCR1/2 signaling, a key receptor pathway necessary for neutrophil recruitment to the site of inflammation showed protection in murine infections with influenza, <italic>Staphylococcus pneumoniae</italic>, or combined infections. Given the prominence of secondary bacterial infections (discussed in detail below) in influenza-associated disease, such host-directed therapies may have significant clinical utility [<xref ref-type="bibr" rid="CR20">20</xref>]. Neutrophils can mediate tissue damage by secreting high levels of tissue remodeling enzymes such as MMPs, but also amplify inflammation by secreting extracellular traps (NETs). In mouse models, NETs were highly correlated with acute lung injury, which could be exacerbated by shifting cellular infiltrates in favor of neutrophils by depleting macrophages [<xref ref-type="bibr" rid="CR21">21</xref>]. Similar NET structures have been observed in humans suffering from severe influenza disease. In one study of severe H7N9 and H1N1pdm09 virus infection, levels of NETs at admission were correlated with clinical scores (APACHE II) [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par13">Targeting host inflammation has been of increasing interest for the development of new therapeutics for severe influenza. One study used the well-characterized mTOR inhibitor rapamycin/sirolimus to suppress inflammation, leading to improved outcomes, correlated with reduced inflammasome activity [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Targeting the mTOR pathway as a means to reduce inflammation and promote recovery implicates host metabolism in the etiology of severe influenza disease, given the central role mTOR plays in nutrient sensing. Metabolic disruptions have been noted in local and systemic analyses of severe cases of influenza [<xref ref-type="bibr" rid="CR25">25</xref>] and metabolic interventions have been shown to alter host response profiles in ways that could be protective or harmful depending on the infection context. For example, in mouse models of bacterial sepsis or influenza virus infection, glucose restriction had opposing effects, protecting against bacterial sepsis but exacerbating influenza-associated disease [<xref ref-type="bibr" rid="CR26">26</xref>]. The role of metabolism in modulating viral infection is complex, as while the host needs particular nutrients to support its immune activities, the virus itself requires significant host cell metabolic resources to maintain its replication, including glucose and glutamine [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Targeting these viral metabolic requirements may open additional therapeutic windows. Additionally, the global metabolic state within a host has been shown to have profound effects on the course of viral infection and the progression to ARDS-phenotypes. Obese animals and humans are significantly more susceptible to severe influenza, with increase in lung injury and sustained viral replication, indicative of failures of host immunity and potentially increased viral pathogenesis. The mechanisms relating to obesity to susceptibility are likely complex and multi-factorial, including increased inflammation and decreased wound healing in obese individuals. Additionally, obesity dampens some features of adaptive immunity that may delay viral clearance or increase susceptibility to initial infection [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec4"><title>Influenza clinical progression to pneumonia and ARDS</title><p id="Par14">Approximately 30&#x02013;40% of the hospitalized patients with laboratory-confirmed influenza are diagnosed with acute pneumonia. These patients who develop pneumonia are more likely to be young (&#x0003c;&#x02009;5&#x02009;years old), old (&#x0003e;&#x02009;65&#x02009;years old), Caucasian, and nursing home residents; have chronic lung or heart disease and history of smoking; and are more commonly immunocompromised. Of note, pregnant women, extreme obesity, Native Americans, and Alaska natives are also more prone to develop severe Influenza complications [<xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref>]. Nonetheless, unlike seasonal epidemics of influenza virus infection that display these classic risk factors, pandemics such as the 2009 H1N1 were associated with a higher rate of hospitalized respiratory failure in previously healthy and young adults [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. More recently, a large cohort from Australia and New Zealand reported that during the winter of 2017, the predominant H3N2 virus strain was associated with unprecedented high levels of ICU admission due to viral and bacterial pneumonias, even higher than 2009 H1N1 pandemic [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par15">There are no reliable statistics on the actual incidence or prevalence of influenza-related ARDS in either pediatric or adult populations. However, it is known that the vast majority of ARDS is caused by bacterial sepsis and non-infectious etiologies such as trauma, pancreatitis, smoke inhalation, and drug toxicity [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Observational studies suggest that within the small proportion of viral-induced ARDS in the pediatric population, most are caused by respiratory syncytial virus and Influenza A, while Influenza A is the predominant viral etiology of ARDS in the adult population [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. A European cohort from the Eurosurveillance showed that the risk factors independently associated with ARDS in patients diagnosed with influenza are age between 36 and 55&#x02009;years old, pregnancy, and obesity, while protective factors associated with ARDS were female sex, influenza vaccination, and infections with Influenza A (H3N2) or Influenza B viruses. Notably, the only factors that remained significantly associated with death were increasing severity score and age greater than 55&#x02009;years old [<xref ref-type="bibr" rid="CR41">41</xref>]. In another cohort from China, it appears that viral strain was a significant factor, as, compared to H1N1, ARDS caused by H7N9 was associated with higher disease severity, higher rates of mechanical complications and hospital-acquired pneumonias, and increased mortality [<xref ref-type="bibr" rid="CR42">42</xref>]. A potential new risk factor for the development of ARDS during the influenza season is the performance of cardiac surgery [<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par16">The challenge of diagnosing pneumonia and ARDS in patients with positive laboratory results for influenza relates to the temporality of the clinical events. Influenza virus infection alone can cause severe pneumonia and ARDS, but it can also act in conjunction with a bacterial infection (discussed below). It can precede a pneumonia episode caused by a secondary bacterial infection, most commonly by <italic>S. aureus</italic> and <italic>S. pneumoniae</italic>, or can be followed by an episode of nosocomial pneumonia [<xref ref-type="bibr" rid="CR44">44</xref>]. Clinicians commonly fail to clinically diagnose influenza in up to two-thirds of patients whom have confirmed influenza virus infection [<xref ref-type="bibr" rid="CR45">45</xref>]. In the case of severe pneumonia or ARDS, the only reliable clue that influenza is a possible causal agent is the presentation during the peak season of the epidemic because the symptomatology alone cannot distinguish severe influenza from other viral or bacterial respiratory infections. Primary influenza pneumonia shows persistence and/or subsequent worsening of respiratory symptoms, while secondary bacterial pneumonia occurs 1&#x02013;3&#x02009;weeks as a &#x0201c;relapse&#x0201d; after the initial Influenza symptoms have ended or subsided; however, bacterial co-infection can also occur a few days after the Influenza illness onset. That said, only 5% of all severe pneumonias admitted to the ICU are from a viral etiology [<xref ref-type="bibr" rid="CR46">46</xref>].</p></sec><sec id="Sec5"><title>Influenza presenting as sepsis</title><p id="Par17">The immune response to influenza shares many common pathways with the response to bacteria, thus it should not be surprising that an influenza virus infection can have a very similar clinical presentation to bacterial sepsis [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Specifically, several studies have demonstrated that both Toll-like receptors 2 and 4, which are the main receptors for Gram-positive and Gram-negative bacteria, are also related to influenza pathogenicity [<xref ref-type="bibr" rid="CR49">49</xref>&#x02013;<xref ref-type="bibr" rid="CR51">51</xref>]. The inflammatory response also varies according to the viral strain; for example, H5N1 virus produces a stronger response than H1N1pdm09 virus and H7N7 in blood macrophages, but H1N1pdm09 produces a more robust cytokine production than other strains [<xref ref-type="bibr" rid="CR52">52</xref>&#x02013;<xref ref-type="bibr" rid="CR54">54</xref>]. In addition, similar to bacterial sepsis, endothelial damage and microvascular permeability changes leading to tissue edema and organ failure have been observed with influenza virus infections [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Analogous to the influenza virus predisposition to secondary bacterial pneumonia, influenza virus increases by 6-fold the progression to secondary bacterial sepsis [<xref ref-type="bibr" rid="CR57">57</xref>]. Adults with severe influenza-induced organ failure and pediatric patients with high PIM scores and acute renal failure have a greater risk of mortality [<xref ref-type="bibr" rid="CR58">58</xref>&#x02013;<xref ref-type="bibr" rid="CR60">60</xref>]. A large multinational cohort evaluating the causes of sepsis in approximately 1600 patients from Southeast Asia found that 4% of all sepsis were caused by influenza viruses [<xref ref-type="bibr" rid="CR61">61</xref>]. In the recent 2017 winter season with the predominant H3N2 virus strain, an Australasian study reported that the ICU admission for sepsis was much higher than expected, which the authors attributed in part to the influenza virus season [<xref ref-type="bibr" rid="CR38">38</xref>].</p></sec><sec id="Sec6"><title>Role of viral-bacterial co-infections and their effect on outcomes</title><p id="Par18">The occurrence of viral-bacterial respiratory co-infections has been described for over a century, including the period of the 1918 influenza pandemic; however, until just a few years ago, the general evidence pointed to this as a uncommon event without major changes on patients&#x02019; outcomes. The recent advent of more rapid and available microbiological diagnostic tests (e.g. real-time reverse-transcriptase polymerase chain reaction) has revealed a very different picture. Nowadays viral etiologies per se are responsible for one-third of all cases of community-acquired pneumonias (CAP) [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. These etiologies include influenza, parainfluenza, coronavirus, rhinovirus, metapneumovirus, adenovirus, respiratory syncytial virus, and other less frequent microorganisms. Viral infections presenting concurrently with bacterial CAP are now known to occur with a frequency of 30&#x02013;50% in both adult and pediatric populations [<xref ref-type="bibr" rid="CR64">64</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref>]. Interestingly, it would be more intuitive to assume that CAP would be the most severe manifestation of these co-infections, but more recently there have been several studies demonstrating these viral-bacterial infections also affect 10&#x02013;20% of patients with hospital-acquired pneumonia (HAP) [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR68">68</xref>&#x02013;<xref ref-type="bibr" rid="CR70">70</xref>]. In a large cohort study with over 2,000 patients hospitalized with severe H1N1pdm09 influenza, the following risk factors were identified for developing HAP: need for mechanical ventilation, sepsis, ICU admission on the first day, lymphocytopenia, older age, and anemia. Of note, growing evidence suggests that 20&#x02013;30% of pediatric and adult patients presenting with suspected bacterial sepsis may have a viral co-infection (e.g. influenza, metapneumovirus, coronavirus, and respiratory syncytial virus) and about two thirds of these cases are commonly missed by clinicians [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. Current data still lacks proof that the clinical presentation with viral-bacterial co-infections directly leads to worse outcomes, but a growing body of evidence suggests that influenza-bacterial co-infections are associated with higher morbidity and higher mortality [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR73">73</xref>&#x02013;<xref ref-type="bibr" rid="CR76">76</xref>]. In fact, a recent study showed that the presence of co-infection in adults with influenza-associated acute respiratory syndrome requiring extra-corporeal membrane oxygenation was significantly associated with a fourfold increase in mortality [<xref ref-type="bibr" rid="CR77">77</xref>], and another study in children with <italic>Staphylococcus aureus</italic> co-infection with influenza-related critical illness also showed a ninefold significant increase in mortality [<xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par19">The mechanism of increased susceptibility to bacterial co-infection after an influenza virus infection has been a focus of many studies. The lung immune environment is substantially altered after influenza virus infection, with early depletion of alveolar macrophages [<xref ref-type="bibr" rid="CR79">79</xref>]. As these cells play a key role in the response to many bacterial infections, their loss may play a critical part in increasing susceptibility. Additionally, the normal regulatory mechanisms that are induced by any inflammatory response are triggered by a viral infection. These include the upregulation of key negative regulators on the surface of lung immune cells, including CD200 on airway macrophages. Such suppressor activity is necessary to allow tissue repair and avoid pathological consequences of overzealous immune responses, but they can allow a window of opportunity for bacteria [<xref ref-type="bibr" rid="CR80">80</xref>]. Similarly, influenza virus infection induces systemic glucocorticoids that can dampen inflammation to protect tissue integrity, but allow increased bacterial growth, as was shown in a mouse model of influenza virus-<italic>Listeria</italic> co-infection [<xref ref-type="bibr" rid="CR81">81</xref>]. Blocking the glucocorticoid response actually led to death from the inflammation associated with the influenza virus infection, demonstrating the balance between tolerance and pathogen resistance that can be difficult to determine in the co-infected host [<xref ref-type="bibr" rid="CR81">81</xref>].</p></sec><sec id="Sec7"><title>Other less common severe complications of Influenza</title><p id="Par20">Acute myositis accompanied by rhabdomyolysis may rarely happen, most commonly in children who present with extreme tenderness of lower extremities, and the laboratory investigation shows marked elevation of serum creatinine phosphokinase and myoglobinuria [<xref ref-type="bibr" rid="CR82">82</xref>]. Myocarditis and pericarditis have also been rarely described in clinical cases, but demonstrated in autopsy studies [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. Central nervous system complications associated with influenza include encephalitis, acute disseminated encephalomyelitis, transverse myelitis, aseptic meningitis, and Guillain-Barre syndrome [<xref ref-type="bibr" rid="CR85">85</xref>&#x02013;<xref ref-type="bibr" rid="CR87">87</xref>] (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Severe influenza complications</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Severe influenza complications</th></tr></thead><tbody><tr><td colspan="2">Influenza pneumonia</td></tr><tr><td colspan="2">Secondary bacterial pneumonia</td></tr><tr><td colspan="2">ARDS</td></tr><tr><td colspan="2">Influenza sepsis</td></tr><tr><td colspan="2">Secondary bacterial sepsis</td></tr><tr><td colspan="2">Myositis and rhabdomyolysis</td></tr><tr><td colspan="2">Acute myocarditis</td></tr><tr><td colspan="2">Acute pericarditis</td></tr><tr><td colspan="2">Acute encephalitis</td></tr><tr><td colspan="2">Acute disseminated encephalomyelitis</td></tr><tr><td colspan="2">Transverse myelitis</td></tr><tr><td colspan="2">Aseptic meningitis</td></tr><tr><td colspan="2">Guillain-Barre syndrome</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec8"><title>Conclusions</title><p id="Par21">Influenza virus affects the respiratory tract by direct viral infection or by damage from the immune system response. In humans, the respiratory epithelium is the only site where the hemagglutinin (HA) molecule is effectively cleaved, generating infectious virus particles. Virus transmission occurs through contact with aerosols or respiratory fomites from an infected individual. The inability of the lung to perform its primary function of gas exchange can result from multiple mechanisms, including obstruction of the airways, loss of alveolar structure, loss of lung epithelial integrity from direct epithelial cell killing, and degradation of the critical extracellular matrix.</p><p id="Par22">Approximately 30&#x02013;40% of hospitalized patients with laboratory-confirmed influenza are diagnosed with acute pneumonia. These patients who develop pneumonia are more likely to be &#x0003c;&#x02009;5&#x02009;years old, &#x0003e;&#x02009;65&#x02009;years old, Caucasian, and nursing home residents; have chronic lung or heart disease and history of smoking; and are immunocompromised.</p><p id="Par23">Influenza can primarily cause severe pneumonia, but it can also present in conjunction with or be followed by a secondary bacterial infection, most commonly by <italic>S. aureus</italic> and <italic>S. pneumoniae</italic>. Influenza is associated with a higher predisposition to bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial pneumonia are now known to occur with a frequency of 30&#x02013;50% in both adult and pediatric populations. Influenza A (H3N2) virus has been associated with unprecedented high levels of intensive care unit (ICU) admission.</p><p id="Par24">Influenza A virus is the predominant viral etiology of acute respiratory distress syndrome (ARDS) in adults. Risk factors independently associated with ARDS are age between 36 and 55&#x02009;years old, pregnancy, and obesity, while protective factors are female sex, influenza vaccination, and infections with Influenza A (H3N2) or Influenza B viruses.</p><p id="Par25">In the ICU, particularly during the winter season, Influenza should be suspected not only in patients with typical symptoms and epidemiology, but also in patients with severe pneumonia, ARDS, sepsis with or without bacterial co-infection, as well as in patients with encephalitis, myocarditis, and rhabdomyolysis.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None.</p><sec id="FPar1"><title>Summary figure</title><p id="Par26">
<list list-type="bullet"><list-item><p id="Par27">Influenza virus affects the respiratory tract by direct viral infection or by damage from the immune system response.</p></list-item><list-item><p id="Par28">Approximately 30&#x02013;40% of hospitalized patients with laboratory-confirmed influenza are diagnosed with acute pneumonia.</p></list-item><list-item><p id="Par29">Coinfections with other viruses and bacteria are common.</p></list-item><list-item><p id="Par30">Influenza should be suspected not only in patients with typical symptoms and epidemiology, but also in patients with severe pneumonia, ARDS, sepsis, encephalitis, myocarditis, and rhabdomyolysis.</p></list-item></list>
</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Both authors wrote the first draft for this manuscript. Both authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>None.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par31">Not applicable.</p></notes><notes><title>Consent for publication</title><p id="Par32">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par33">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Webster RG, Braciale TJ, Monto AS, Lamb RA. Textbook of influenza. 2nd edition. ed. Chichester, West Sussex, UK ; Hoboken, NJ: Wiley-Blackwell; 2013. xvii, 502 pages p.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakdawala</surname><given-names>SS</given-names></name><name><surname>Jayaraman</surname><given-names>A</given-names></name><name><surname>Halpin</surname><given-names>RA</given-names></name><name><surname>Lamirande</surname><given-names>EW</given-names></name><name><surname>Shih</surname><given-names>AR</given-names></name><name><surname>Stockwell</surname><given-names>TB</given-names></name><etal/></person-group><article-title>The soft palate is an important site of adaptation for transmissible influenza viruses</article-title><source>Nature.</source><year>2015</year><volume>526</volume><issue>7571</issue><fpage>122</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/nature15379</pub-id><?supplied-pmid 26416728?><pub-id pub-id-type="pmid">26416728</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>JM</given-names></name><name><surname>Bourne</surname><given-names>AJ</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Peiris</surname><given-names>JS</given-names></name></person-group><article-title>Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses</article-title><source>Respir Res</source><year>2007</year><volume>8</volume><fpage>73</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-8-73</pub-id><?supplied-pmid 17961210?><pub-id pub-id-type="pmid">17961210</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zangrillo</surname><given-names>A</given-names></name><name><surname>Biondi-Zoccai</surname><given-names>G</given-names></name><name><surname>Landoni</surname><given-names>G</given-names></name><name><surname>Frati</surname><given-names>G</given-names></name><name><surname>Patroniti</surname><given-names>N</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO</article-title><source>Crit Care</source><year>2013</year><volume>17</volume><issue>1</issue><fpage>R30</fpage><pub-id pub-id-type="doi">10.1186/cc12512</pub-id><?supplied-pmid 23406535?><pub-id pub-id-type="pmid">23406535</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadoglou</surname><given-names>NPE</given-names></name><name><surname>Bracke</surname><given-names>F</given-names></name><name><surname>Simmers</surname><given-names>T</given-names></name><name><surname>Tsiodras</surname><given-names>S</given-names></name><name><surname>Parissis</surname><given-names>J</given-names></name></person-group><article-title>Influenza infection and heart failure-vaccination may change heart failure prognosis?</article-title><source>Heart Fail Rev</source><year>2017</year><volume>22</volume><issue>3</issue><fpage>329</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1007/s10741-017-9614-7</pub-id><?supplied-pmid 28508293?><pub-id pub-id-type="pmid">28508293</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>JC</given-names></name><name><surname>Schwartz</surname><given-names>KL</given-names></name><name><surname>Campitelli</surname><given-names>MA</given-names></name></person-group><article-title>Acute myocardial infarction after laboratory-confirmed influenza infection</article-title><source>N Engl J Med</source><year>2018</year><volume>378</volume><issue>26</issue><fpage>2540</fpage><lpage>2541</lpage><?supplied-pmid 29949484?><pub-id pub-id-type="pmid">29949484</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>CJ</given-names></name><name><surname>Vogel</surname><given-names>P</given-names></name><name><surname>McClaren</surname><given-names>JL</given-names></name><name><surname>Bajracharya</surname><given-names>R</given-names></name><name><surname>Doherty</surname><given-names>PC</given-names></name><name><surname>Thomas</surname><given-names>PG</given-names></name></person-group><article-title>Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2013</year><volume>304</volume><issue>7</issue><fpage>L481</fpage><lpage>L488</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00343.2012</pub-id><?supplied-pmid 23355384?><pub-id pub-id-type="pmid">23355384</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardani</surname><given-names>A</given-names></name><name><surname>Boulton</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name></person-group><article-title>Alveolar macrophages prevent lethal influenza pneumonia by inhibiting infection of type-1 alveolar epithelial cells</article-title><source>PLoS Pathog</source><year>2017</year><volume>13</volume><issue>1</issue><fpage>e1006140</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1006140</pub-id><?supplied-pmid 28085958?><pub-id pub-id-type="pmid">28085958</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teijaro</surname><given-names>JR</given-names></name><name><surname>Walsh</surname><given-names>KB</given-names></name><name><surname>Cahalan</surname><given-names>S</given-names></name><name><surname>Fremgen</surname><given-names>DM</given-names></name><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>F</given-names></name><etal/></person-group><article-title>Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection</article-title><source>Cell.</source><year>2011</year><volume>146</volume><issue>6</issue><fpage>980</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.08.015</pub-id><?supplied-pmid 21925319?><pub-id pub-id-type="pmid">21925319</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>DF</given-names></name><name><surname>Thomas</surname><given-names>PG</given-names></name></person-group><article-title>Towards integrating extracellular matrix and immunological pathways</article-title><source>Cytokine.</source><year>2017</year><volume>98</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2017.03.004</pub-id><?supplied-pmid 28325629?><pub-id pub-id-type="pmid">28325629</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>KR</given-names></name><name><surname>Kroeze</surname><given-names>E</given-names></name><name><surname>Fouchier</surname><given-names>RAM</given-names></name><name><surname>Kuiken</surname><given-names>T</given-names></name></person-group><article-title>Pathogenesis of influenza-induced acute respiratory distress syndrome</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><issue>1</issue><fpage>57</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70286-X</pub-id><?supplied-pmid 24239327?><pub-id pub-id-type="pmid">24239327</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quantius</surname><given-names>J</given-names></name><name><surname>Schmoldt</surname><given-names>C</given-names></name><name><surname>Vazquez-Armendariz</surname><given-names>AI</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>El Agha</surname><given-names>E</given-names></name><name><surname>Wilhelm</surname><given-names>J</given-names></name><etal/></person-group><article-title>Influenza virus infects epithelial stem/progenitor cells of the distal lung: impact on Fgfr2b-driven epithelial repair</article-title><source>PLoS Pathog</source><year>2016</year><volume>12</volume><issue>6</issue><fpage>e1005544</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005544</pub-id><?supplied-pmid 27322618?><pub-id pub-id-type="pmid">27322618</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneghan</surname><given-names>CJ</given-names></name><name><surname>Onakpoya</surname><given-names>I</given-names></name><name><surname>Jones</surname><given-names>MA</given-names></name><name><surname>Doshi</surname><given-names>P</given-names></name><name><surname>Del Mar</surname><given-names>CB</given-names></name><name><surname>Hama</surname><given-names>R</given-names></name><etal/></person-group><article-title>Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data</article-title><source>Health Technol Assess</source><year>2016</year><volume>20</volume><issue>42</issue><fpage>1</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.3310/hta20420</pub-id><?supplied-pmid 27246259?><pub-id pub-id-type="pmid">27246259</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talmi-Frank</surname><given-names>D</given-names></name><name><surname>Altboum</surname><given-names>Z</given-names></name><name><surname>Solomonov</surname><given-names>I</given-names></name><name><surname>Udi</surname><given-names>Y</given-names></name><name><surname>Jaitin</surname><given-names>DA</given-names></name><name><surname>Klepfish</surname><given-names>M</given-names></name><etal/></person-group><article-title>Extracellular matrix proteolysis by MT1-MMP contributes to Influenza-related tissue damage and mortality</article-title><source>Cell Host Microbe</source><year>2016</year><volume>20</volume><issue>4</issue><fpage>458</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.09.005</pub-id><?supplied-pmid 27736644?><pub-id pub-id-type="pmid">27736644</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Rojas-Quintero J, Wang X, Tipper J, Burkett PR, Zuniga J, Ashtekar AR, et al. Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection. JCI Insight. 2018;3(24). 10.1172/jci.insight.99022.</mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>IC</given-names></name><name><surname>Scull</surname><given-names>MA</given-names></name><name><surname>Moore</surname><given-names>CB</given-names></name><name><surname>Holl</surname><given-names>EK</given-names></name><name><surname>McElvania-TeKippe</surname><given-names>E</given-names></name><name><surname>Taxman</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA</article-title><source>Immunity.</source><year>2009</year><volume>30</volume><issue>4</issue><fpage>556</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.005</pub-id><?supplied-pmid 19362020?><pub-id pub-id-type="pmid">19362020</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>PG</given-names></name><name><surname>Dash</surname><given-names>P</given-names></name><name><surname>Aldridge</surname><given-names>JR</given-names><suffix>Jr</suffix></name><name><surname>Ellebedy</surname><given-names>AH</given-names></name><name><surname>Reynolds</surname><given-names>C</given-names></name><name><surname>Funk</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1</article-title><source>Immunity.</source><year>2009</year><volume>30</volume><issue>4</issue><fpage>566</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.006</pub-id><?supplied-pmid 19362023?><pub-id pub-id-type="pmid">19362023</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>7625</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-07384-5</pub-id><?supplied-pmid 28790324?><pub-id pub-id-type="pmid">28790324</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>MD</given-names></name><name><surname>Ong</surname><given-names>JD</given-names></name><name><surname>Dowling</surname><given-names>JK</given-names></name><name><surname>McAuley</surname><given-names>JL</given-names></name><name><surname>Robertson</surname><given-names>AB</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><etal/></person-group><article-title>Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>27912</fpage><pub-id pub-id-type="doi">10.1038/srep27912</pub-id><?supplied-pmid 27283237?><pub-id pub-id-type="pmid">27283237</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavares</surname><given-names>LP</given-names></name><name><surname>Garcia</surname><given-names>CC</given-names></name><name><surname>Machado</surname><given-names>MG</given-names></name><name><surname>Queiroz-Junior</surname><given-names>CM</given-names></name><name><surname>Barthelemy</surname><given-names>A</given-names></name><name><surname>Trottein</surname><given-names>F</given-names></name><etal/></person-group><article-title>CXCR1/2 antagonism is protective during Influenza and post-influenza pneumococcal infection</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>1799</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.01799</pub-id><?supplied-pmid 29326698?><pub-id pub-id-type="pmid">29326698</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narasaraju</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>Samy</surname><given-names>RP</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Poh</surname><given-names>WP</given-names></name><name><surname>Liew</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis</article-title><source>Am J Pathol</source><year>2011</year><volume>179</volume><issue>1</issue><fpage>199</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.03.013</pub-id><?supplied-pmid 21703402?><pub-id pub-id-type="pmid">21703402</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>High level of neutrophil extracellular traps correlates with poor prognosis of severe Influenza a infection</article-title><source>J Infect Dis</source><year>2018</year><volume>217</volume><issue>3</issue><fpage>428</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1093/infdis/jix475</pub-id><?supplied-pmid 29325098?><pub-id pub-id-type="pmid">29325098</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Lv</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration</article-title><source>PLoS Pathog</source><year>2018</year><volume>14</volume><issue>11</issue><fpage>e1007428</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1007428</pub-id><?supplied-pmid 30422993?><pub-id pub-id-type="pmid">30422993</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CH</given-names></name><name><surname>Chung</surname><given-names>FT</given-names></name><name><surname>Lin</surname><given-names>SM</given-names></name><name><surname>Huang</surname><given-names>SY</given-names></name><name><surname>Chou</surname><given-names>CL</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><etal/></person-group><article-title>Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure</article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><issue>2</issue><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3182a2727d</pub-id><?supplied-pmid 24105455?><pub-id pub-id-type="pmid">24105455</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Fatty acid metabolism is associated with disease severity after H7N9 infection</article-title><source>EBioMedicine.</source><year>2018</year><volume>33</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.06.019</pub-id><?supplied-pmid 29941340?><pub-id pub-id-type="pmid">29941340</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Huen</surname><given-names>SC</given-names></name><name><surname>Luan</surname><given-names>HH</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Gallezot</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation</article-title><source>Cell.</source><year>2016</year><volume>166</volume><issue>6</issue><fpage>1512</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.026</pub-id><?supplied-pmid 27610573?><pub-id pub-id-type="pmid">27610573</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smallwood</surname><given-names>HS</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Morfouace</surname><given-names>M</given-names></name><name><surname>Rezinciuc</surname><given-names>S</given-names></name><name><surname>Shulkin</surname><given-names>BL</given-names></name><name><surname>Shelat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Targeting metabolic reprogramming by influenza infection for therapeutic intervention</article-title><source>Cell Rep</source><year>2017</year><volume>19</volume><issue>8</issue><fpage>1640</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.039</pub-id><?supplied-pmid 28538182?><pub-id pub-id-type="pmid">28538182</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thai</surname><given-names>M</given-names></name><name><surname>Thaker</surname><given-names>SK</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Ting Wu</surname><given-names>T</given-names></name><etal/></person-group><article-title>MYC-induced reprogramming of glutamine catabolism supports optimal virus replication</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>8873</fpage><pub-id pub-id-type="doi">10.1038/ncomms9873</pub-id><?supplied-pmid 26561297?><pub-id pub-id-type="pmid">26561297</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>HE</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Sanchez</surname><given-names>N</given-names></name><name><surname>Ng</surname><given-names>S</given-names></name><name><surname>Gresh</surname><given-names>L</given-names></name><name><surname>Ojeda</surname><given-names>S</given-names></name><etal/></person-group><article-title>Obesity increases the duration of influenza a virus shedding in adults</article-title><source>J Infect Dis</source><year>2018</year><volume>218</volume><issue>9</issue><fpage>1378</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiy370</pub-id><?supplied-pmid 30085119?><pub-id pub-id-type="pmid">30085119</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>KB</given-names></name><name><surname>Vogel</surname><given-names>P</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Govorkova</surname><given-names>EA</given-names></name><name><surname>Webby</surname><given-names>RJ</given-names></name><name><surname>McCullers</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Impaired wound healing predisposes obese mice to severe influenza virus infection</article-title><source>J Infect Dis</source><year>2012</year><volume>205</volume><issue>2</issue><fpage>252</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir729</pub-id><?supplied-pmid 22147799?><pub-id pub-id-type="pmid">22147799</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paich</surname><given-names>HA</given-names></name><name><surname>Sheridan</surname><given-names>PA</given-names></name><name><surname>Handy</surname><given-names>J</given-names></name><name><surname>Karlsson</surname><given-names>EA</given-names></name><name><surname>Schultz-Cherry</surname><given-names>S</given-names></name><name><surname>Hudgens</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus</article-title><source>Obesity (Silver Spring)</source><year>2013</year><volume>21</volume><issue>11</issue><fpage>2377</fpage><lpage>2386</lpage><pub-id pub-id-type="doi">10.1002/oby.20383</pub-id><pub-id pub-id-type="pmid">23512822</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casalino</surname><given-names>E</given-names></name><name><surname>Antoniol</surname><given-names>S</given-names></name><name><surname>Fidouh</surname><given-names>N</given-names></name><name><surname>Choquet</surname><given-names>C</given-names></name><name><surname>Lucet</surname><given-names>JC</given-names></name><name><surname>Duval</surname><given-names>X</given-names></name><etal/></person-group><article-title>Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: a 3-year prospective observational study during seasonal epidemic periods</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>8</issue><fpage>e0182191</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0182191</pub-id><?supplied-pmid 28813449?><pub-id pub-id-type="pmid">28813449</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>T</given-names></name><name><surname>Fujisawa</surname><given-names>T</given-names></name><name><surname>Suga</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Nagao</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Outcomes and prognostic features of patients with Influenza requiring hospitalization and receiving early antiviral therapy: a prospective multicenter cohort study</article-title><source>Chest.</source><year>2016</year><volume>149</volume><issue>2</issue><fpage>526</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1378/chest.14-2768</pub-id><?supplied-pmid 26203671?><pub-id pub-id-type="pmid">26203671</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Dawood</surname><given-names>FS</given-names></name><name><surname>Jhung</surname><given-names>M</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>D'Mello</surname><given-names>T</given-names></name><etal/></person-group><article-title>Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008</article-title><source>BMC Infect Dis</source><year>2015</year><volume>15</volume><fpage>369</fpage><pub-id pub-id-type="doi">10.1186/s12879-015-1004-y</pub-id><?supplied-pmid 26307108?><pub-id pub-id-type="pmid">26307108</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uyeki</surname><given-names>Timothy M</given-names></name><name><surname>Bernstein</surname><given-names>Henry H</given-names></name><name><surname>Bradley</surname><given-names>John S</given-names></name><name><surname>Englund</surname><given-names>Janet A</given-names></name><name><surname>File</surname><given-names>Thomas M</given-names></name><name><surname>Fry</surname><given-names>Alicia M</given-names></name><name><surname>Gravenstein</surname><given-names>Stefan</given-names></name><name><surname>Hayden</surname><given-names>Frederick G</given-names></name><name><surname>Harper</surname><given-names>Scott A</given-names></name><name><surname>Hirshon</surname><given-names>Jon Mark</given-names></name><name><surname>Ison</surname><given-names>Michael G</given-names></name><name><surname>Johnston</surname><given-names>B Lynn</given-names></name><name><surname>Knight</surname><given-names>Shandra L</given-names></name><name><surname>McGeer</surname><given-names>Allison</given-names></name><name><surname>Riley</surname><given-names>Laura E</given-names></name><name><surname>Wolfe</surname><given-names>Cameron R</given-names></name><name><surname>Alexander</surname><given-names>Paul E</given-names></name><name><surname>Pavia</surname><given-names>Andrew T</given-names></name></person-group><article-title>Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa</article-title><source>Clinical Infectious Diseases</source><year>2018</year><volume>68</volume><issue>6</issue><fpage>e1</fpage><lpage>e47</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy866</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louie</surname><given-names>JK</given-names></name><name><surname>Acosta</surname><given-names>M</given-names></name><name><surname>Winter</surname><given-names>K</given-names></name><name><surname>Jean</surname><given-names>C</given-names></name><name><surname>Gavali</surname><given-names>S</given-names></name><name><surname>Schechter</surname><given-names>R</given-names></name><etal/></person-group><article-title>Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California</article-title><source>JAMA.</source><year>2009</year><volume>302</volume><issue>17</issue><fpage>1896</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1583</pub-id><?supplied-pmid 19887665?><pub-id pub-id-type="pmid">19887665</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Writing Committee of the WHOCoCAoPI</collab><name><surname>Bautista</surname><given-names>E</given-names></name><name><surname>Chotpitayasunondh</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Harper</surname><given-names>SA</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><etal/></person-group><article-title>Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><issue>18</issue><fpage>1708</fpage><lpage>1719</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1000449</pub-id><pub-id pub-id-type="pmid">20445182</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrell</surname><given-names>A</given-names></name><name><surname>Huckson</surname><given-names>S</given-names></name><name><surname>Pilcher</surname><given-names>DV</given-names></name><collab>Anzics</collab></person-group><article-title>ICU admissions for Sepsis or pneumonia in Australia and New Zealand in 2017</article-title><source>N Engl J Med</source><year>2018</year><volume>378</volume><issue>22</issue><fpage>2138</fpage><lpage>2139</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1717178</pub-id><?supplied-pmid 29847767?><pub-id pub-id-type="pmid">29847767</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ike</surname><given-names>JD</given-names></name><name><surname>Kempker</surname><given-names>JA</given-names></name><name><surname>Kramer</surname><given-names>MR</given-names></name><name><surname>Martin</surname><given-names>GS</given-names></name></person-group><article-title>The association between acute respiratory distress syndrome hospital case volume and mortality in a U.S. cohort, 2002-2011</article-title><source>Crit Care Med</source><year>2018</year><volume>46</volume><issue>5</issue><fpage>764</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000003015</pub-id><?supplied-pmid 29394181?><pub-id pub-id-type="pmid">29394181</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schouten</surname><given-names>LR</given-names></name><name><surname>Veltkamp</surname><given-names>F</given-names></name><name><surname>Bos</surname><given-names>AP</given-names></name><name><surname>van Woensel</surname><given-names>JB</given-names></name><name><surname>Serpa Neto</surname><given-names>A</given-names></name><name><surname>Schultz</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis</article-title><source>Crit Care Med</source><year>2016</year><volume>44</volume><issue>4</issue><fpage>819</fpage><lpage>829</lpage><?supplied-pmid 26509320?><pub-id pub-id-type="pmid">26509320</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Bonmarin Isabelle BE, Jean B, Christian B-B, Bruno M, Loup CJ, Bruno H, Yann LS, Daniel L-B. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons. Euro Surveill. 2015;20(46).</mixed-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Weng</surname><given-names>H</given-names></name><name><surname>Lan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Comparison of patients with avian influenza A (H7N9) and influenza a (H1N1) complicated by acute respiratory distress syndrome</article-title><source>Medicine (Baltimore)</source><year>2018</year><volume>97</volume><issue>12</issue><fpage>e0194</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000010194</pub-id><pub-id pub-id-type="pmid">29561442</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groeneveld</surname><given-names>GH</given-names></name><name><surname>van Paassen</surname><given-names>J</given-names></name><name><surname>van Dissel</surname><given-names>JT</given-names></name><name><surname>Arbous</surname><given-names>MS</given-names></name></person-group><article-title>Influenza season and ARDS after cardiac surgery</article-title><source>N Engl J Med</source><year>2018</year><volume>378</volume><issue>8</issue><fpage>772</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1712727</pub-id><?supplied-pmid 29466160?><pub-id pub-id-type="pmid">29466160</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Xue</surname><given-names>CX</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><etal/></person-group><article-title>Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients</article-title><source>Respir Med</source><year>2018</year><volume>134</volume><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2017.11.017</pub-id><?supplied-pmid 29413513?><pub-id pub-id-type="pmid">29413513</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dugas</surname><given-names>AF</given-names></name><name><surname>Valsamakis</surname><given-names>A</given-names></name><name><surname>Atreya</surname><given-names>MR</given-names></name><name><surname>Thind</surname><given-names>K</given-names></name><name><surname>Alarcon Manchego</surname><given-names>P</given-names></name><name><surname>Faisal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Clinical diagnosis of influenza in the ED</article-title><source>Am J Emerg Med</source><year>2015</year><volume>33</volume><issue>6</issue><fpage>770</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2015.03.008</pub-id><?supplied-pmid 25827595?><pub-id pub-id-type="pmid">25827595</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Asten</surname><given-names>L</given-names></name><name><surname>Luna Pinzon</surname><given-names>A</given-names></name><name><surname>de Lange</surname><given-names>DW</given-names></name><name><surname>de Jonge</surname><given-names>E</given-names></name><name><surname>Dijkstra</surname><given-names>F</given-names></name><name><surname>Marbus</surname><given-names>S</given-names></name><etal/></person-group><article-title>Estimating severity of influenza epidemics from severe acute respiratory infections (SARI) in intensive care units</article-title><source>Crit Care</source><year>2018</year><volume>22</volume><issue>1</issue><fpage>351</fpage><pub-id pub-id-type="doi">10.1186/s13054-018-2274-8</pub-id><?supplied-pmid 30567568?><pub-id pub-id-type="pmid">30567568</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>BE</given-names></name><name><surname>Goldenberg</surname><given-names>NM</given-names></name><name><surname>Lee</surname><given-names>WL</given-names></name></person-group><article-title>Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods</article-title><source>Antivir Res</source><year>2012</year><volume>93</volume><issue>1</issue><fpage>2</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2011.10.019</pub-id><?supplied-pmid 22068147?><pub-id pub-id-type="pmid">22068147</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florescu</surname><given-names>DF</given-names></name><name><surname>Kalil</surname><given-names>AC</given-names></name></person-group><article-title>The complex link between influenza and severe sepsis</article-title><source>Virulence.</source><year>2014</year><volume>5</volume><issue>1</issue><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.4161/viru.27103</pub-id><?supplied-pmid 24253109?><pub-id pub-id-type="pmid">24253109</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Kuba</surname><given-names>K</given-names></name><name><surname>Neely</surname><given-names>GG</given-names></name><name><surname>Yaghubian-Malhami</surname><given-names>R</given-names></name><name><surname>Perkmann</surname><given-names>T</given-names></name><name><surname>van Loo</surname><given-names>G</given-names></name><etal/></person-group><article-title>Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury</article-title><source>Cell.</source><year>2008</year><volume>133</volume><issue>2</issue><fpage>235</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.02.043</pub-id><?supplied-pmid 18423196?><pub-id pub-id-type="pmid">18423196</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nhu</surname><given-names>QM</given-names></name><name><surname>Shirey</surname><given-names>K</given-names></name><name><surname>Teijaro</surname><given-names>JR</given-names></name><name><surname>Farber</surname><given-names>DL</given-names></name><name><surname>Netzel-Arnett</surname><given-names>S</given-names></name><name><surname>Antalis</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo</article-title><source>Mucosal Immunol</source><year>2010</year><volume>3</volume><issue>1</issue><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/mi.2009.120</pub-id><?supplied-pmid 19865078?><pub-id pub-id-type="pmid">19865078</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirey</surname><given-names>KA</given-names></name><name><surname>Lai</surname><given-names>W</given-names></name><name><surname>Scott</surname><given-names>AJ</given-names></name><name><surname>Lipsky</surname><given-names>M</given-names></name><name><surname>Mistry</surname><given-names>P</given-names></name><name><surname>Pletneva</surname><given-names>LM</given-names></name><etal/></person-group><article-title>The TLR4 antagonist Eritoran protects mice from lethal influenza infection</article-title><source>Nature.</source><year>2013</year><volume>497</volume><issue>7450</issue><fpage>498</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/nature12118</pub-id><?supplied-pmid 23636320?><pub-id pub-id-type="pmid">23636320</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friesenhagen</surname><given-names>J</given-names></name><name><surname>Boergeling</surname><given-names>Y</given-names></name><name><surname>Hrincius</surname><given-names>E</given-names></name><name><surname>Ludwig</surname><given-names>S</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Viemann</surname><given-names>D</given-names></name></person-group><article-title>Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages</article-title><source>J Leukoc Biol</source><year>2012</year><volume>92</volume><issue>1</issue><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1189/jlb.0911479</pub-id><?supplied-pmid 22442495?><pub-id pub-id-type="pmid">22442495</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>CY</given-names></name><name><surname>Poon</surname><given-names>LL</given-names></name><name><surname>Lau</surname><given-names>AS</given-names></name><name><surname>Luk</surname><given-names>W</given-names></name><name><surname>Lau</surname><given-names>YL</given-names></name><name><surname>Shortridge</surname><given-names>KF</given-names></name><etal/></person-group><article-title>Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?</article-title><source>Lancet.</source><year>2002</year><volume>360</volume><issue>9348</issue><fpage>1831</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11772-7</pub-id><?supplied-pmid 12480361?><pub-id pub-id-type="pmid">12480361</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakabe</surname><given-names>S</given-names></name><name><surname>Iwatsuki-Horimoto</surname><given-names>K</given-names></name><name><surname>Takano</surname><given-names>R</given-names></name><name><surname>Nidom</surname><given-names>CA</given-names></name><name><surname>Le</surname><given-names>M</given-names></name><name><surname>Nagamura-Inoue</surname><given-names>T</given-names></name><etal/></person-group><article-title>Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses</article-title><source>J Gen Virol</source><year>2011</year><volume>92</volume><issue>Pt 6</issue><fpage>1428</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1099/vir.0.030346-0</pub-id><?supplied-pmid 21367984?><pub-id pub-id-type="pmid">21367984</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Le</surname><given-names>TQ</given-names></name><name><surname>Kurihara</surname><given-names>N</given-names></name><name><surname>Chida</surname><given-names>J</given-names></name><name><surname>Cisse</surname><given-names>Y</given-names></name><name><surname>Yano</surname><given-names>M</given-names></name><etal/></person-group><article-title>Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza</article-title><source>J Infect Dis</source><year>2010</year><volume>202</volume><issue>7</issue><fpage>991</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1086/656044</pub-id><?supplied-pmid 20731583?><pub-id pub-id-type="pmid">20731583</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>SM</given-names></name><name><surname>Mubareka</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>WL</given-names></name></person-group><article-title>The lung microvascular endothelium as a therapeutic target in severe influenza</article-title><source>Antivir Res</source><year>2013</year><volume>99</volume><issue>2</issue><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.05.003</pub-id><?supplied-pmid 23685311?><pub-id pub-id-type="pmid">23685311</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Benoit</surname><given-names>SR</given-names></name><name><surname>Skarbinski</surname><given-names>J</given-names></name><name><surname>Bramley</surname><given-names>AM</given-names></name><name><surname>Finelli</surname><given-names>L</given-names></name><name><surname>Pandemic Influenza</surname><given-names>AVHIT</given-names></name></person-group><article-title>Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus--United States, 2009</article-title><source>Clin Infect Dis</source><year>2012</year><volume>54</volume><issue>9</issue><fpage>1221</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1093/cid/cis197</pub-id><?supplied-pmid 22437239?><pub-id pub-id-type="pmid">22437239</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Zarychanski</surname><given-names>R</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Lacroix</surname><given-names>J</given-names></name><etal/></person-group><article-title>Critically ill patients with 2009 influenza A(H1N1) infection in Canada</article-title><source>JAMA.</source><year>2009</year><volume>302</volume><issue>17</issue><fpage>1872</fpage><lpage>1879</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1496</pub-id><?supplied-pmid 19822627?><pub-id pub-id-type="pmid">19822627</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Cherit</surname><given-names>G</given-names></name><name><surname>Lapinsky</surname><given-names>SE</given-names></name><name><surname>Macias</surname><given-names>AE</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Espinosa-Perez</surname><given-names>L</given-names></name><name><surname>de la Torre</surname><given-names>A</given-names></name><etal/></person-group><article-title>Critically ill patients with 2009 influenza A(H1N1) in Mexico</article-title><source>JAMA.</source><year>2009</year><volume>302</volume><issue>17</issue><fpage>1880</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1536</pub-id><?supplied-pmid 19822626?><pub-id pub-id-type="pmid">19822626</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>JA</given-names></name><name><surname>Fernandez</surname><given-names>A</given-names></name><name><surname>Monteverde</surname><given-names>E</given-names></name><name><surname>Vidal</surname><given-names>N</given-names></name><name><surname>Arias</surname><given-names>P</given-names></name><name><surname>Montes</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina</article-title><source>Intensive Care Med</source><year>2010</year><volume>36</volume><issue>6</issue><fpage>1015</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1007/s00134-010-1853-1</pub-id><?supplied-pmid 20237757?><pub-id pub-id-type="pmid">20237757</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Southeast Asia Infectious Disease Clinical Research N</collab></person-group><article-title>Causes and outcomes of sepsis in Southeast Asia: a multinational multicentre cross-sectional study</article-title><source>Lancet Glob Health</source><year>2017</year><volume>5</volume><issue>2</issue><fpage>e157</fpage><lpage>ee67</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(17)30007-4</pub-id><pub-id pub-id-type="pmid">28104185</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aliberti</surname><given-names>S</given-names></name><name><surname>Kaye</surname><given-names>KS</given-names></name></person-group><article-title>The changing microbiologic epidemiology of community-acquired pneumonia</article-title><source>Postgrad Med</source><year>2013</year><volume>125</volume><issue>6</issue><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.3810/pgm.2013.11.2710</pub-id><?supplied-pmid 24200759?><pub-id pub-id-type="pmid">24200759</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Self</surname><given-names>WH</given-names></name><name><surname>Balk</surname><given-names>RA</given-names></name><name><surname>Grijalva</surname><given-names>CG</given-names></name><name><surname>Williams</surname><given-names>DJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Anderson</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia</article-title><source>Clin Infect Dis</source><year>2017</year><volume>65</volume><issue>2</issue><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1093/cid/cix317</pub-id><?supplied-pmid 28407054?><pub-id pub-id-type="pmid">28407054</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cawcutt</surname><given-names>K</given-names></name><name><surname>Kalil</surname><given-names>AC</given-names></name></person-group><article-title>Pneumonia with bacterial and viral coinfection</article-title><source>Curr Opin Crit Care</source><year>2017</year><volume>23</volume><issue>5</issue><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1097/MCC.0000000000000435</pub-id><?supplied-pmid 28777158?><pub-id pub-id-type="pmid">28777158</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voiriot</surname><given-names>G</given-names></name><name><surname>Visseaux</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>LB</given-names></name><name><surname>Neuville</surname><given-names>M</given-names></name><name><surname>Morbieu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia</article-title><source>Crit Care</source><year>2016</year><volume>20</volume><issue>1</issue><fpage>375</fpage><pub-id pub-id-type="doi">10.1186/s13054-016-1517-9</pub-id><?supplied-pmid 27852281?><pub-id pub-id-type="pmid">27852281</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Self</surname><given-names>WH</given-names></name><name><surname>Williams</surname><given-names>DJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Ampofo</surname><given-names>K</given-names></name><name><surname>Pavia</surname><given-names>AT</given-names></name><name><surname>Chappell</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia</article-title><source>J Infect Dis</source><year>2016</year><volume>213</volume><issue>4</issue><fpage>584</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiv323</pub-id><?supplied-pmid 26180044?><pub-id pub-id-type="pmid">26180044</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>MH</given-names></name><name><surname>Cross</surname><given-names>KE</given-names></name><name><surname>Benitez</surname><given-names>AJ</given-names></name><name><surname>Hicks</surname><given-names>LA</given-names></name><name><surname>Kutty</surname><given-names>P</given-names></name><name><surname>Bramley</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Identification of bacterial and viral codetections with mycoplasma pneumoniae using the TaqMan array card in patients hospitalized with community-acquired pneumonia</article-title><source>Open Forum Infect Dis</source><year>2016</year><volume>3</volume><issue>2</issue><fpage>ofw071</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofw071</pub-id><?supplied-pmid 27191004?><pub-id pub-id-type="pmid">27191004</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loubet</surname><given-names>P</given-names></name><name><surname>Voiriot</surname><given-names>G</given-names></name><name><surname>Houhou-Fidouh</surname><given-names>N</given-names></name><name><surname>Neuville</surname><given-names>M</given-names></name><name><surname>Bouadma</surname><given-names>L</given-names></name><name><surname>Lescure</surname><given-names>FX</given-names></name><etal/></person-group><article-title>Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study</article-title><source>J Clin Virol</source><year>2017</year><volume>91</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2017.04.001</pub-id><?supplied-pmid 28494435?><pub-id pub-id-type="pmid">28494435</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shorr</surname><given-names>AF</given-names></name><name><surname>Zilberberg</surname><given-names>MD</given-names></name><name><surname>Micek</surname><given-names>ST</given-names></name><name><surname>Kollef</surname><given-names>MH</given-names></name></person-group><article-title>Viruses are prevalent in non-ventilated hospital-acquired pneumonia</article-title><source>Respir Med</source><year>2017</year><volume>122</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2016.11.023</pub-id><?supplied-pmid 27993295?><pub-id pub-id-type="pmid">27993295</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>HL</given-names></name><name><surname>Hong</surname><given-names>SB</given-names></name><name><surname>Ko</surname><given-names>GB</given-names></name><name><surname>Huh</surname><given-names>JW</given-names></name><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Do</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>e95865</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0095865</pub-id><?supplied-pmid 24752070?><pub-id pub-id-type="pmid">24752070</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aykac</surname><given-names>K</given-names></name><name><surname>Karadag-Oncel</surname><given-names>E</given-names></name><name><surname>Tanir Basaranoglu</surname><given-names>S</given-names></name><name><surname>Alp</surname><given-names>A</given-names></name><name><surname>Cengiz</surname><given-names>AB</given-names></name><name><surname>Ceyhan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Respiratory viral infections in infants with possible sepsis</article-title><source>J Med Virol</source><year>2019</year><volume>91</volume><issue>2</issue><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1002/jmv.25309</pub-id><?supplied-pmid 30192397?><pub-id pub-id-type="pmid">30192397</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ljungstrom</surname><given-names>LR</given-names></name><name><surname>Jacobsson</surname><given-names>G</given-names></name><name><surname>Claesson</surname><given-names>BEB</given-names></name><name><surname>Andersson</surname><given-names>R</given-names></name><name><surname>Enroth</surname><given-names>H</given-names></name></person-group><article-title>Respiratory viral infections are underdiagnosed in patients with suspected sepsis</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2017</year><volume>36</volume><issue>10</issue><fpage>1767</fpage><lpage>1776</lpage><pub-id pub-id-type="doi">10.1007/s10096-017-2990-z</pub-id><?supplied-pmid 28516200?><pub-id pub-id-type="pmid">28516200</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cawcutt</surname><given-names>KA</given-names></name><name><surname>Kalil</surname><given-names>AC</given-names></name></person-group><article-title>Viral and bacterial co-infection in pneumonia: do we know enough to improve clinical care?</article-title><source>Crit Care</source><year>2017</year><volume>21</volume><issue>1</issue><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/s13054-016-1592-y</pub-id><?supplied-pmid 28122641?><pub-id pub-id-type="pmid">28122641</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Loeches</surname><given-names>I</given-names></name><name><surname>J Schultz</surname><given-names>M</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Alvarez-Lerma</surname><given-names>F</given-names></name><name><surname>Bos</surname><given-names>LD</given-names></name><name><surname>Sole-Violan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Increased incidence of co-infection in critically ill patients with influenza</article-title><source>Intensive Care Med</source><year>2017</year><volume>43</volume><issue>1</issue><fpage>48</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s00134-016-4578-y</pub-id><?supplied-pmid 27709265?><pub-id pub-id-type="pmid">27709265</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>AG</given-names></name><name><surname>Vaughn</surname><given-names>F</given-names></name><name><surname>Sullivan</surname><given-names>R</given-names></name><name><surname>Rubinson</surname><given-names>L</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Yoon</surname><given-names>G</given-names></name><etal/></person-group><article-title>Critically ill children during the 2009-2010 influenza pandemic in the United States</article-title><source>Pediatrics.</source><year>2011</year><volume>128</volume><issue>6</issue><fpage>e1450</fpage><lpage>e1458</lpage><pub-id pub-id-type="doi">10.1542/peds.2011-0774</pub-id><?supplied-pmid 22065262?><pub-id pub-id-type="pmid">22065262</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>TW</given-names></name><name><surname>Rubinson</surname><given-names>L</given-names></name><name><surname>Uyeki</surname><given-names>TM</given-names></name><name><surname>Vaughn</surname><given-names>FL</given-names></name><name><surname>John</surname><given-names>BB</given-names></name><name><surname>Miller</surname><given-names>RR</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States</article-title><source>Crit Care Med</source><year>2012</year><volume>40</volume><issue>5</issue><fpage>1487</fpage><lpage>1498</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3182416f23</pub-id><?supplied-pmid 22511131?><pub-id pub-id-type="pmid">22511131</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozencwajg</surname><given-names>S</given-names></name><name><surname>Brechot</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Hekimian</surname><given-names>G</given-names></name><name><surname>Lebreton</surname><given-names>G</given-names></name><name><surname>Besset</surname><given-names>S</given-names></name><etal/></person-group><article-title>Co-infection with influenza-associated acute respiratory distress syndrome requiring extracorporeal membrane oxygenation</article-title><source>Int J Antimicrob Agents</source><year>2018</year><volume>51</volume><issue>3</issue><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.11.005</pub-id><?supplied-pmid 29174419?><pub-id pub-id-type="pmid">29174419</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>AG</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Novak</surname><given-names>T</given-names></name><name><surname>Newhams</surname><given-names>MM</given-names></name><name><surname>Bubeck Wardenburg</surname><given-names>J</given-names></name><name><surname>Weiss</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Vancomycin monotherapy may be insufficient to treat methicillin-resistant Staphylococcus aureus coinfection in children with influenza-related critical illness</article-title><source>Clin Infect Dis</source><year>2019</year><volume>68</volume><issue>3</issue><fpage>365</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy495</pub-id><?supplied-pmid 29893805?><pub-id pub-id-type="pmid">29893805</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoneim</surname><given-names>HE</given-names></name><name><surname>Thomas</surname><given-names>PG</given-names></name><name><surname>McCullers</surname><given-names>JA</given-names></name></person-group><article-title>Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections</article-title><source>J Immunol</source><year>2013</year><volume>191</volume><issue>3</issue><fpage>1250</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1300014</pub-id><?supplied-pmid 23804714?><pub-id pub-id-type="pmid">23804714</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goulding</surname><given-names>J</given-names></name><name><surname>Godlee</surname><given-names>A</given-names></name><name><surname>Vekaria</surname><given-names>S</given-names></name><name><surname>Hilty</surname><given-names>M</given-names></name><name><surname>Snelgrove</surname><given-names>R</given-names></name><name><surname>Hussell</surname><given-names>T</given-names></name></person-group><article-title>Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection</article-title><source>J Infect Dis</source><year>2011</year><volume>204</volume><issue>7</issue><fpage>1086</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir467</pub-id><?supplied-pmid 21881124?><pub-id pub-id-type="pmid">21881124</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamieson</surname><given-names>AM</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Annicelli</surname><given-names>CH</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title>Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection</article-title><source>Cell Host Microbe</source><year>2010</year><volume>7</volume><issue>2</issue><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2010.01.010</pub-id><?supplied-pmid 20159617?><pub-id pub-id-type="pmid">20159617</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dell</surname><given-names>KM</given-names></name><name><surname>Schulman</surname><given-names>SL</given-names></name></person-group><article-title>Rhabdomyolysis and acute renal failure in a child with influenza a infection</article-title><source>Pediatr Nephrol</source><year>1997</year><volume>11</volume><issue>3</issue><fpage>363</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1007/s004670050299</pub-id><?supplied-pmid 9203195?><pub-id pub-id-type="pmid">9203195</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamas</surname><given-names>MA</given-names></name><name><surname>Fraser</surname><given-names>D</given-names></name><name><surname>Neyses</surname><given-names>L</given-names></name></person-group><article-title>Cardiovascular manifestations associated with influenza virus infection</article-title><source>Int J Cardiol</source><year>2008</year><volume>130</volume><issue>3</issue><fpage>304</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2008.04.044</pub-id><?supplied-pmid 18625525?><pub-id pub-id-type="pmid">18625525</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paddock</surname><given-names>CD</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Denison</surname><given-names>AM</given-names></name><name><surname>Bartlett</surname><given-names>JH</given-names></name><name><surname>Holman</surname><given-names>RC</given-names></name><name><surname>Deleon-Carnes</surname><given-names>M</given-names></name><etal/></person-group><article-title>Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection</article-title><source>J Infect Dis</source><year>2012</year><volume>205</volume><issue>6</issue><fpage>895</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir861</pub-id><?supplied-pmid 22291193?><pub-id pub-id-type="pmid">22291193</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goenka</surname><given-names>A</given-names></name><name><surname>Michael</surname><given-names>BD</given-names></name><name><surname>Ledger</surname><given-names>E</given-names></name><name><surname>Hart</surname><given-names>IJ</given-names></name><name><surname>Absoud</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>G</given-names></name><etal/></person-group><article-title>Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><issue>6</issue><fpage>775</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1093/cid/cit922</pub-id><?supplied-pmid 24352349?><pub-id pub-id-type="pmid">24352349</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuno</surname><given-names>H</given-names></name><name><surname>Yahata</surname><given-names>Y</given-names></name><name><surname>Tanaka-Taya</surname><given-names>K</given-names></name><name><surname>Arai</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Morino</surname><given-names>S</given-names></name><etal/></person-group><article-title>Characteristics and outcomes of Influenza-associated encephalopathy cases among children and adults in Japan, 2010-2015</article-title><source>Clin Infect Dis</source><year>2018</year><volume>66</volume><issue>12</issue><fpage>1831</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1093/cid/cix1126</pub-id><?supplied-pmid 29293894?><pub-id pub-id-type="pmid">29293894</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellers</surname><given-names>SA</given-names></name><name><surname>Hagan</surname><given-names>RS</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Fischer</surname><given-names>WA</given-names><suffix>2nd</suffix></name></person-group><article-title>The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection</article-title><source>Influenza Other Respir Viruses</source><year>2017</year><volume>11</volume><issue>5</issue><fpage>372</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1111/irv.12470</pub-id><?supplied-pmid 28745014?><pub-id pub-id-type="pmid">28745014</pub-id></element-citation></ref></ref-list></back></article>